Drug industry
Article Abstract:
Drug industry stocks are either sinking or are just on the level. Investors may find some components of interest given the industry's diversity. The drug industry is predicted to be a mediocre performer in the year 2004. Investors need to keep the size of the company in mind before investing. A detailed study of some companies is provided.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Merck and Co
Article Abstract:
A comparative analysis of the company sales and earnings and the financial details of Merck and Co. from 1988 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic: